HUMAN COMBINATORIAL AUTOANTIBODIES AND MOUSE MONOCLONAL-ANTIBODIES TOPDC-E2 PRODUCE ABNORMAL APICAL STAINING OF SALIVARY-GLANDS IN PATIENTS WITH COEXISTENT PRIMARY BILIARY-CIRRHOSIS AND SJOGRENS-SYNDROME
K. Tsuneyama et al., HUMAN COMBINATORIAL AUTOANTIBODIES AND MOUSE MONOCLONAL-ANTIBODIES TOPDC-E2 PRODUCE ABNORMAL APICAL STAINING OF SALIVARY-GLANDS IN PATIENTS WITH COEXISTENT PRIMARY BILIARY-CIRRHOSIS AND SJOGRENS-SYNDROME, Hepatology, 20(4), 1994, pp. 893-898
An increase in the incidence of Sjogren's syndrome in patients with pr
imary biliary cirrhosis has been noted. Indeed, primary biliary cirrho
sis has been described as a ductal disease with involvement not only o
f the biliary tract but of epithelial ductal cells in other organs. We
have previously reported the development of a panel of mouse monoclon
al antibodies directed at PDC-E2, the major autoantigen of primary bil
iary cirrhosis. One such antibody, C355.1, but none of the other monoc
lonal antibodies, reacted not only with mitochondria but also with the
apical region of biliary epithelium of patients with primary biliary
cirrhosis but not in similar specimens from patients with other liver
disease or normal human liver. In addition, we have reported the devel
opment of human combinatorial antibodies specific for PDC-E2; these re
agents also reacted uniquely with the biliary epithelium of patients w
ith primary biliary cirrhosis. In this paper, we have performed a simi
lar study and have compared the staining of monoclonal antibody C355.1
and a human combinatorial antibody, SP4, with control monoclonal anti
bodies with respect to their reactivity of salivary glands in 9 patien
ts with primary biliary cirrhosis associated with Sjogren's syndrome,
11 patients with Sjogren's syndrome alone and 7 control patients. Inte
restingly, the apical region of the salivary gland epithelial cells of
approximately 50% of patients with coexisting primary biliary cirrhos
is and Sjogren's syndrome had a staining pattern similar to that seen
in primary biliary cirrhosis biliary epithelium. In contrast, we did n
ot observe this reactivity in any patient with Sjogren's syndrome alon
e or in any control patient. These data suggest that similar mechanism
s may explain the abnormal expression pattern of PDC-E2 or a cross-rea
cting molecule in the ductal tissue of patients with primary biliary c
irrhosis.